The Ohio Cardiovascular & Diabetes Health Collaborative (Cardi-OH) is a statewide initiative of health care professionals who share knowledge to improve Medicaid patient outcomes and eliminate health disparities across Ohio.
Describe the epidemiology of obesity and its intersection with diabetes.
Understand the roles of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) for diabetes and weight loss.
Prescribe effective and necessary lifestyle modifications as an accompaniment to pharmacological therapy.
Currentsprovide brief summaries of the latest advances in medicine or clinical practice related to diabetes or hypertension and include links to additional resources.
View a highlight from the New and Emerging Wearable Devices clinic on February 2, 2023, featuring Adam Perzynski, PhD, from Case Western Reserve University.
Want to see more? View videos of previous clinics led by our content experts.
VisitCardi-OH.orgto read more about the collaborative and our latest best practices.
Sharing best practices to improve
cardiovascular and diabetes health
The Ohio Cardiovascular and Diabetes Health Collaborative is funded by the Ohio Department of Medicaid and administered by the Ohio Colleges of Medicine Government Resource Center. The views expressed in this document are solely those of the authors and do not represent the views of the state of Ohio or federal Medicaid programs.
